Does tranexamic acid help in postpartum haemorrhage?
Tranexamic acid (TXA) reduces death due to bleeding in women with postpartum haemorrhage when given early. In the WOMAN trial (~20,000 women across 21 countries), TXA significantly reduced death due to bleeding, with no increase in adverse events including thromboembolism [1].
The benefit was greatest when TXA was given within 3 hours of birth; treatment given later showed no clear benefit, supporting early administration as soon as PPH is diagnosed [1]. TXA did not reduce hysterectomy, as the decision often preceded or accompanied treatment.
Overall all-cause mortality was not significantly reduced, and TXA is an adjunct to — not a replacement for — standard uterotonic and surgical management of PPH [1]. WHO and major obstetric bodies recommend early TXA in established PPH.
- Benefit is time-critical: efficacy is confined to administration within ~3 hours of birth.
- The trial showed reduced death from bleeding but not a significant reduction in overall mortality or hysterectomy.
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
Illustrative example of a CliniAtlas reading, for professional reference only. Verify as a healthcare professional to ask your own questions against live sources.